Hard to Treat Diseases, Inc. (HTDS) Reports from Mina Mar's 2nd Annual Shareholders Conference

Read Full Report Here

Positive influence of hyperbaric oxygenation on recovery from brain trauma

Read Full Report Here

Hard to Treat Diseases (HTDS) Plans a Share Buyback Program - March 29, 2010

Read Full Report Here

RD expenditures 2009

Read Full Report Here

Hard to Treat Diseases (HTDS) Resolves Its Short Position with Scottrade - Shenzen, China, March 11, 2010 - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) announces that Scottrade lifted trading restriction on the HTDS security. Scottrade, the American discount retail brokerage firm, removed the restriction of online trading and buys of HTDS security, as HTDS successfully resolved the issue regarding the company's short position. The company sees this a right move from the brokerage firm and will work diligently to achieve and lift all similar restrictions with brokerages that filed HTDS in their bad books.

Read Full Report Here

Hard to Treat Diseases (HTDS) Melem Secrets' Completes Merger - BEIJING, CHINA, Feb. 25 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) - Further to the previously announced cosmetics merger (press release Feb 5, 2010) negotiations with the cosmetic company Melem Secrets, and other business matters the company is pleased to report that it has completed a cosmetic micro-conglomerate merger.

Read Full Report Here

Chile Buys 2 Million Doses of Swine-Flu Vaccine SANTIAGO The Chilean government has purchased 2 million doses of the vaccine against the AH1N1 flu virus for the immunization campaign that begins in the second half of March, the Health Ministry said.

Read Full Report Here